Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma
Clinical trial NCT03837977 · COMPLETED
Trial details
- NCT number
- NCT03837977
- Sponsor
- The Christie NHS Foundation Trust
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-13
- Primary completion
- 2024-11-26
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.